Physostigmine in amoxapine overdose
Ross, S.R.; Rodgers, S.R.
American Journal of Hospital Pharmacy 38(8): 1121-1122
1981
ISSN/ISBN: 0002-9289 PMID: 7270554 Document Number: 172108
Document emailed within 1 workday
Related Documents
Chu, C.C.; Wadle, C.V.; Ruedrich, S.L. 1984: Acute renal failure associated with amoxapine overdose Nebraska Medical Journal 69(10): 338-339Goldberg, M.J.; Spector, R. 1982: Amoxapine overdose: report of two patients with severe neurologic damage Annals of Internal Medicine 96(4): 463-464
Knapp, S.; Wardlow, M.L.; Albert, K.; Waters, D.; Thal, L.J. 1991: Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjects Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 400-404
Soravisut, N.; Rattanasalee, P.; Junkuy, A.; Thampitak, S.; Sribanditmongkol, P. 2011: Comparative analysis of pathological and toxicological features of opiate overdose and non-overdose fatalities Journal of the Medical Association of Thailand 94(12): 1540-1546
Calvo, B.; García, M.J.; Pedraz, J.L.; Mariño, E.L.; Domínguez-Gil, A. 1985: Pharmacokinetics of amoxapine and its active metabolites International Journal of Clinical Pharmacology Therapy and Toxicology 23(4): 180-185
Jennings, A.E.; Levey, A.S.; Harrington, J.T. 1983: Amoxapine-associated acute renal failure Archives of Internal Medicine 143(8): 1525-1527
Midha, K.K.; Hubbard, J.W.; McKay, G.; Rawson, M.J.; Hsia, D. 1999: The role of metabolites in a bioequivalence study II: amoxapine, 7-hydroxyamoxapine, and 8-hydroxyamoxapine International Journal of Clinical Pharmacology and Therapeutics 37(9): 428-438
Navrátil, J.; Sklenovský, A.; Petr, J. 1989: The possibilities of clinical application of physostigmine Acta Universitatis Palackianae Olomucensis Facultatis Medicae 122: 159-162
Donchin, Y.; Ramu, A.; Dudai, M.; Granite, D. 1979: Treatment of dibenzepin poisoning with physostigmine Harefuah 97(7-8): 163-164
Kai-Håkon, C. 1977: Antihistamine poisoning. Treatment with physostigmine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 97(25): 1262-1263
Trose, D.; Slowig, P. 1985: Stabilization of physostigmine salicylate injection solutions Die Pharmazie 40(2): 124-126
Navrátil, J.; Sklenovský, A.; Chmela, Z.; Rypka, M. 1989: Perspectives of physostigmine as antidote by toluene intoxication Acta Universitatis Palackianae Olomucensis Facultatis Medicae 121: 267-270
Stojek, A.; Bilikiewicz, A.; Napierala, K. 1986: Physostigmine in alcohol withdrawal: a new clinical approach Journal of Clinical Psychiatry 47(10): 530
Winters, W.D.; Kott, K.S. 1976: Neuropharmacological interaction between ketamine, and physostigmine, diazepam or propranolol Proceedings of the Western Pharmacology Society 19: 232-236
Davis, K.L.; Mohs, R.C.; Davis, B.M.; Horvath, T.B.; Tinklenberg, J.R.; Rosenberg, G.S.; Levy, M.I. 1980: Human memory and the effects of physostigmine and choline chloride Psychopharmacology Bulletin 16(4): 27-28
Kovács, T.; Szabó, B. 1972: Effect of physostigmine on Li uptake of frog sartorius muscle Acta Physiologica Academiae Scientiarum Hungaricae 42(4): 377-386
Hill, S.Y.; Reyes, R.B.; Kupfer, D.J. 1979: Physostigmine induction of REM sleep in imipramine treated rats Communications in Psychopharmacology 3(4): 261-266
Kovács, T.; Szabó, B. 1971: Effect of physostigmine on sodium efflux of frog muscle Acta Physiologica Academiae Scientiarum Hungaricae 40(1): 15-26
Amlo, H.; Haugeng, K.L.; Wickstrøm, E.; Koss, A.; Husebye, T.; Jacobsen, D. 1997: Poisoning with Jimson weed. Five cases treated with physostigmine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(18): 2610-2612
Varagić, V.M.; Prostran, M.S. 1991: Modulating effect of adenosine on the hypertensive response to physostigmine Archives Internationales de Pharmacodynamie et de Therapie 311: 144-154